Abstract
Polycystic ovary syndrome is the most common endocrinopathy recognized in women of childbearing age with a prevalence of 4-12%. The prevalence of the disorder in adolescent population is poorly defined. The pathogenesis as well as the management of this disorder is widely debated.
Copyright © 2013 Mosby, Inc. All rights reserved.
MeSH terms
-
Acneiform Eruptions / blood
-
Acneiform Eruptions / drug therapy
-
Acneiform Eruptions / etiology*
-
Adolescent
-
Adolescent Health Services
-
Atherosclerosis / blood
-
Atherosclerosis / etiology
-
Atherosclerosis / prevention & control*
-
Early Diagnosis
-
Female
-
Follicle Stimulating Hormone / blood
-
Humans
-
Hyperandrogenism / blood
-
Hyperandrogenism / diagnosis*
-
Hyperandrogenism / drug therapy
-
Infertility, Female / blood
-
Infertility, Female / etiology
-
Infertility, Female / prevention & control*
-
Luteinizing Hormone / blood
-
Obesity / blood
-
Obesity / complications
-
Obesity / prevention & control*
-
Physicians
-
Polycystic Ovary Syndrome* / blood
-
Polycystic Ovary Syndrome* / complications
-
Polycystic Ovary Syndrome* / diagnosis
-
Polycystic Ovary Syndrome* / drug therapy
-
Prevalence
-
Testosterone / blood
Substances
-
Testosterone
-
Luteinizing Hormone
-
Follicle Stimulating Hormone